Cargando…

In silico molecular docking analysis for repurposing therapeutics against multiple proteins from SARS-CoV-2

SARS-CoV-2 has devastated the world with its rapid spread and fatality. The researchers across the globe are struggling hard to search a drug to treat this infection. Understanding the time constraint, the best approach is to study clinically approved drugs for control of this deadly pandemic of COV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deshpande, Rujuta R., Tiwari, Arpita Pandey, Nyayanit, Narendra, Modak, Manisha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2020
Materias:	Full Length Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398085/ https://www.ncbi.nlm.nih.gov/pubmed/32758569 http://dx.doi.org/10.1016/j.ejphar.2020.173430

Ejemplares similares

In silico pharmacokinetic and molecular docking studies of natural flavonoids and synthetic indole chalcones against essential proteins of SARS-CoV-2
por: Vijayakumar, Balaji Gowrivel, et al.
Publicado: (2020)

In silico identification of strong binders of the SARS-CoV-2 receptor-binding domain
por: Behloul, Nouredine, et al.
Publicado: (2021)

Berries anthocyanins as potential SARS-CoV–2 inhibitors targeting the viral attachment and replication; molecular docking simulation
por: Messaoudi, Omar, et al.
Publicado: (2021)

Magical bullets from an indigenous Indian medicinal plant Tinospora cordifolia: An in silico approach for the antidote of SARS-CoV-2()
por: Thakkar, Sampark S., et al.
Publicado: (2021)

Ofatumumab Monoclonal Antibody Affinity Maturation Through in silico Modeling
por: Payandeh, Zahra, et al.
Publicado: (2018)

Screening Malaria-box compounds to identify potential inhibitors against SARS-CoV-2 M(pro), using molecular docking and dynamics simulation studies
por: Ahamad, Shahzaib, et al.
Publicado: (2021)

Unravelling high-affinity binding compounds towards transmembrane protease serine 2 enzyme in treating SARS-CoV-2 infection using molecular modelling and docking studies
por: M, Pooja, et al.
Publicado: (2021)

Strong Dual Antipolymerase/Antiexonuclease Actions of Some Aminothiadiazole Antioxidants: A Promising In-Silico/In-Vitro Repurposing Research Study against the COVID-19 Omicron Virus (B.1.1.529.3 Lineage)
por: Rabie, Amgad M., et al.
Publicado: (2023)

In silico Screening and Evaluation of the Anticonvulsant Activity of Docosahexaenoic Acid-Like Molecules in Experimental Models of Seizures
por: Loron, Ali Gharibi, et al.
Publicado: (2017)

In silico Evaluation of PLAC1-fliC As a Chimeric Vaccine against Breast Cancer
por: Taheri-Anganeh, Mortaza, et al.
Publicado: (2020)

In silico Analysis of Pasteurella multocida PlpE Protein Epitopes As Novel Subunit Vaccine Candidates
por: Mostaan, Saied, et al.
Publicado: (2021)

Approaches and advances in the development of potential therapeutic targets and antiviral agents for the management of SARS-CoV-2 infection
por: Krishna, Gayathri, et al.
Publicado: (2020)

Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting
por: Sharifkashani, Sourena, et al.
Publicado: (2020)

In silico Identification of Hypoxic Signature followed by reverse transcription-quantitative PCR Validation in Cancer Cell Lines
por: Shayan, Sara, et al.
Publicado: (2023)

Multiple sites on SARS‐CoV‐2 spike protein are susceptible to proteolysis by cathepsins B, K, L, S, and V
por: Bollavaram, Keval, et al.
Publicado: (2021)

Breakthrough SARS‐CoV‐2 infections in immune mediated disease patients undergoing B cell depleting therapy: A retrospective cohort analysis
por: Calabrese, Cassandra M, et al.
Publicado: (2022)

Analysis of humoral and cellular immunity after SARS-CoV-2 vaccination in patients with multiple sclerosis treated with immunomodulatory drugs
por: Meca-Lallana, Virginia, et al.
Publicado: (2023)

Viroinformatics approach to explore the inhibitory mechanism of existing drugs repurposed to fight against COVID-19
por: Bibi, Nousheen, et al.
Publicado: (2020)

Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19
por: Islam, Tania, et al.
Publicado: (2020)

In silico molecular docking analysis for repurposing approved antiviral drugs against SARS-CoV-2 main protease
por: Khater, Ibrahim, et al.
Publicado: (2021)

In Silico Identification of Potential Inhibitors of the SARS-CoV-2 Nucleocapsid Through Molecular Docking-Based Drug Repurposing
por: Afreen, Rukhsar, et al.
Publicado: (2022)

Effect of Multiple Intraperitoneal Injections of Human Bone Marrow Mesenchymal Stem Cells on Cuprizone Model of Multiple Sclerosis
por: Marzban, Mohsen, et al.
Publicado: (2018)

Functional and druggability analysis of the SARS-CoV-2 proteome
por: Cavasotto, Claudio N., et al.
Publicado: (2021)

Multipolymer microsphere delivery of SARS-CoV-2 antigens
por: Shahjin, Farah, et al.
Publicado: (2023)

Architecture and self‐assembly of the SARS‐CoV‐2 nucleocapsid protein
por: Ye, Qiaozhen, et al.
Publicado: (2020)

Unclear but present danger: An asymptomatic SARS-CoV-2 carrier
por: Yu, Xuejing, et al.
Publicado: (2020)

Genomics functional analysis and drug screening of SARS-CoV-2
por: Chen, Long, et al.
Publicado: (2020)

Nonstructural protein 7 and 8 complexes of SARS‐CoV‐2
por: Zhang, Changhui, et al.
Publicado: (2021)

DNA-scaffolded multivalent vaccine against SARS-CoV-2
por: Chen, Fangfang, et al.
Publicado: (2023)

Differential immune activation profile of SARS-CoV-2 and SARS-CoV infection in human lung and intestinal cells: Implications for treatment with IFN-β and IFN inducer
por: Shuai, Huiping, et al.
Publicado: (2020)

Prophylactic and Therapeutic Effects of Oleuropein on Reperfusion-Induced Arrhythmia in Anesthetized Rat
por: Baharvand, Babak, et al.
Publicado: (2016)

Role of Intravesical BCG as a Therapeutic Vaccine for Treatment of Bladder Carcinoma
por: Doroud, Delaram, et al.
Publicado: (2022)

Mechanisms of instantaneous inactivation of SARS-CoV-2 by silicon nitride bioceramic
por: Pezzotti, G., et al.
Publicado: (2021)

Identification of potent small molecule inhibitors of SARS-CoV-2 entry
por: Mediouni, Sonia, et al.
Publicado: (2022)

Computational and theoretical exploration for clinical suitability of Remdesivir drug to SARS-CoV-2
por: Nayeem, Shaik Mahammad, et al.
Publicado: (2021)

Silencing SARS‐CoV Spike protein expression in cultured cells by RNA interference
por: Zhang, Yuanjiang, et al.
Publicado: (2004)

Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection
por: Liguori, Claudio, et al.
Publicado: (2020)

SARS-CoV2 neutralizing activity of ozone on porous and non-porous materials
por: Wolfgruber, Stella, et al.
Publicado: (2022)

Low rate of detection of SARS-CoV-2 RNA in deceased tissue donors
por: Greenwald, Melissa A., et al.
Publicado: (2022)

Quality Control of Widely Used Therapeutic Recombinant Proteins by a Novel Real-Time PCR Approach
por: Mamnoon, Babak, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_p8jn13q3f5la0bl97nhvijhuul